阴性乳腺癌-话题@MedSci

#阴性乳腺癌#

226篇内容 | 3215人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2047980, encodeId=7d26204e9803b, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=PNAS：TDP43可以作为三阴性乳腺癌治疗的潜在靶标, objectType=article, longId=134202, objectId=772e13420254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=772e13420254, replyNumber=0, likeNumber=52, createdTime=2018-04-30, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=772e13420254, moduleTitle=PNAS：TDP43可以作为三阴性乳腺癌治疗的潜在靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=772e13420254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047962, encodeId=f63e204e96223, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Science Advances:三阴性乳腺癌患者福音，科学家成功恢复了乳腺癌突变蛋白！, objectType=article, longId=113576, objectId=b7f61135e6f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7f61135e6f5, replyNumber=0, likeNumber=66, createdTime=2018-07-09, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7f61135e6f5, moduleTitle=Science Advances:三阴性乳腺癌患者福音，科学家成功恢复了乳腺癌突变蛋白！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7f61135e6f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047964, encodeId=5b64204e96414, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Oncotarget：三阴性乳腺癌遇强敌，三药联合成功攻克癌症！, objectType=article, longId=114406, objectId=f3981144069b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3981144069b, replyNumber=0, likeNumber=64, createdTime=2018-03-09, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3981144069b, moduleTitle=Oncotarget：三阴性乳腺癌遇强敌，三药联合成功攻克癌症！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3981144069b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047963, encodeId=f934204e963a1, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Sci Advan：三阴性乳腺癌患者福音，科学家成功恢复了乳腺癌突变蛋白！, objectType=article, longId=113577, objectId=af971135e71e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af971135e71e, replyNumber=0, likeNumber=76, createdTime=2018-07-31, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af971135e71e, moduleTitle=Sci Advan：三阴性乳腺癌患者福音，科学家成功恢复了乳腺癌突变蛋白！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af971135e71e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047984, encodeId=5ac1204e984a1, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=袁芃教授：晚期三阴性乳腺癌内科治疗进展（二）, objectType=article, longId=137223, objectId=768b13e22365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=768b13e22365, replyNumber=0, likeNumber=67, createdTime=2018-05-14, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=768b13e22365, moduleTitle=袁芃教授：晚期三阴性乳腺癌内科治疗进展（二）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=768b13e22365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047961, encodeId=fda6204e961e1, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？, objectType=article, longId=113380, objectId=f8ed113380c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ed113380c7, replyNumber=0, likeNumber=72, createdTime=2018-09-01, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ed113380c7, moduleTitle=β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ed113380c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047950, encodeId=908d204e95022, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=PLoS Genet：三阴性乳腺癌与同源重组缺陷有关！, objectType=article, longId=103613, objectId=0c6010361354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c6010361354, replyNumber=0, likeNumber=65, createdTime=2018-04-02, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c6010361354, moduleTitle=PLoS Genet：三阴性乳腺癌与同源重组缺陷有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c6010361354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047960, encodeId=009c204e9608f, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Cancer Res：KDM4酶抑制剂为三阴性乳腺癌患者带来福音, objectType=article, longId=113223, objectId=f56a11322375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f56a11322375, replyNumber=0, likeNumber=69, createdTime=2018-03-31, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f56a11322375, moduleTitle=Cancer Res：KDM4酶抑制剂为三阴性乳腺癌患者带来福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f56a11322375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047981, encodeId=ba94204e98139, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=CLIN CANCER RES：新辅助卡铂和多西他赛治疗的三阴性乳腺癌患者的病理缓解情况, objectType=article, longId=136502, objectId=919713650250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=919713650250, replyNumber=0, likeNumber=55, createdTime=2018-12-07, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=919713650250, moduleTitle=CLIN CANCER RES：新辅助卡铂和多西他赛治疗的三阴性乳腺癌患者的病理缓解情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=919713650250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047975, encodeId=31c1204e9754d, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=JCO：Enzalutamide治疗雄激素受体表达三阴性乳腺癌, objectType=article, longId=128012, objectId=d8f5128012e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8f5128012e9, replyNumber=0, likeNumber=52, createdTime=2018-03-21, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8f5128012e9, moduleTitle=JCO：Enzalutamide治疗雄激素受体表达三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8f5128012e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047968, encodeId=73d0204e9682e, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=[ABC4]范志民教授：三阴性乳腺癌治疗不再止于化疗, objectType=article, longId=119092, objectId=d9f21190920a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9f21190920a, replyNumber=0, likeNumber=53, createdTime=2018-04-18, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9f21190920a, moduleTitle=[ABC4]范志民教授：三阴性乳腺癌治疗不再止于化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9f21190920a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047978, encodeId=4390204e9784a, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=研究人员发现三阴性乳腺癌的“新靶点”, objectType=article, longId=132352, objectId=dccb13235202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dccb13235202, replyNumber=0, likeNumber=46, createdTime=2018-05-26, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dccb13235202, moduleTitle=研究人员发现三阴性乳腺癌的“新靶点”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dccb13235202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047973, encodeId=654c204e9737f, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=J Clin Oncol：外周血cfDNA中的肿瘤分数可以预测转移性三阴性乳腺癌的预后, objectType=article, longId=125829, objectId=a23912582962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a23912582962, replyNumber=0, likeNumber=118, createdTime=2018-07-22, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a23912582962, moduleTitle=J Clin Oncol：外周血cfDNA中的肿瘤分数可以预测转移性三阴性乳腺癌的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a23912582962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047966, encodeId=0392204e966e4, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Int J Cancer：如何评估HER2阴性乳腺癌患者的长期预后？, objectType=article, longId=114639, objectId=ef9e114639a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef9e114639a8, replyNumber=0, likeNumber=97, createdTime=2018-06-26, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef9e114639a8, moduleTitle=Int J Cancer：如何评估HER2阴性乳腺癌患者的长期预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef9e114639a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047957, encodeId=34ea204e9577b, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Theranostics :小分子化合物YD277通过激活内质网应激抑制三阴性乳腺癌, objectType=article, longId=108314, objectId=544310831440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=544310831440, replyNumber=0, likeNumber=55, createdTime=2018-02-21, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=544310831440, moduleTitle=Theranostics :小分子化合物YD277通过激活内质网应激抑制三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=544310831440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047979, encodeId=7d44204e9793b, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Breast Cancer Res Treat：三阴性乳腺癌突变与复发率无关, objectType=article, longId=133975, objectId=2d4a1339e5a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d4a1339e5a2, replyNumber=0, likeNumber=71, createdTime=2018-07-20, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d4a1339e5a2, moduleTitle=Breast Cancer Res Treat：三阴性乳腺癌突变与复发率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d4a1339e5a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047952, encodeId=964f204e9520f, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=JAMA Oncology：三阴性乳腺癌基因突变状态、病理完全缓解与无病生存, objectType=article, longId=105568, objectId=d2b71055684c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b71055684c, replyNumber=0, likeNumber=55, createdTime=2017-11-20, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b71055684c, moduleTitle=JAMA Oncology：三阴性乳腺癌基因突变状态、病理完全缓解与无病生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2b71055684c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047948, encodeId=296e204e94831, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Cell Discovery：“神药”二甲双胍可以抑制三阴性乳腺癌干细胞, objectType=article, longId=97116, objectId=3f879e116e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f879e116e5, replyNumber=0, likeNumber=92, createdTime=2017-09-16, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f879e116e5, moduleTitle=Cell Discovery：“神药”二甲双胍可以抑制三阴性乳腺癌干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f879e116e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047976, encodeId=d41f204e976e9, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Nat Commun：促进三阴性乳腺癌扩散转移的“核心原因”已确定, objectType=article, longId=129654, objectId=bf991296541b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf991296541b, replyNumber=0, likeNumber=59, createdTime=2018-04-30, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf991296541b, moduleTitle=Nat Commun：促进三阴性乳腺癌扩散转移的“核心原因”已确定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf991296541b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047969, encodeId=2e31204e9690a, content=<a href='/topic/show?id=12e49e53102' target=_blank style='color:#2F92EE;'>#阴性乳腺癌#</a>, objectTitle=Oncotarget ：三阴性乳腺癌新突破：科学家首次识别全新治疗靶点, objectType=article, longId=120320, objectId=e4ad120320d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ad120320d1, replyNumber=0, likeNumber=53, createdTime=2018-04-04, rootId=0, userName=circumcision, userId=f65b226, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ad120320d1, moduleTitle=Oncotarget ：三阴性乳腺癌新突破：科学家首次识别全新治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ad120320d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阴性乳腺癌

2020-05-29

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

PNAS：TDP43可以作为三阴性乳腺癌治疗的潜在靶标

2018-04-30

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Science Advances:三阴性乳腺癌患者福音，科学家成功恢复了乳腺癌突变蛋白！

2018-07-09

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Oncotarget：三阴性乳腺癌遇强敌，三药联合成功攻克癌症！

2018-03-09

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Sci Advan：三阴性乳腺癌患者福音，科学家成功恢复了乳腺癌突变蛋白！

2018-07-31

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

袁芃教授：晚期三阴性乳腺癌内科治疗进展（二）

2018-05-14

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

β受体拮抗剂是否可以延长晚期HER2阴性乳腺癌患者生存时间？

2018-09-01

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

PLoS Genet：三阴性乳腺癌与同源重组缺陷有关！

2018-04-02

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Cancer Res：KDM4酶抑制剂为三阴性乳腺癌患者带来福音

2018-03-31

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

CLIN CANCER RES：新辅助卡铂和多西他赛治疗的三阴性乳腺癌患者的病理缓解情况

2018-12-07

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

JCO：Enzalutamide治疗雄激素受体表达三阴性乳腺癌

2018-03-21

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

[ABC4]范志民教授：三阴性乳腺癌治疗不再止于化疗

2018-04-18

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

研究人员发现三阴性乳腺癌的“新靶点”

2018-05-26

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

J Clin Oncol：外周血cfDNA中的肿瘤分数可以预测转移性三阴性乳腺癌的预后

2018-07-22

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Int J Cancer：如何评估HER2阴性乳腺癌患者的长期预后？

2018-06-26

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Theranostics :小分子化合物YD277通过激活内质网应激抑制三阴性乳腺癌

2018-02-21

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Breast Cancer Res Treat：三阴性乳腺癌突变与复发率无关

2018-07-20

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

JAMA Oncology：三阴性乳腺癌基因突变状态、病理完全缓解与无病生存

2017-11-20

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Cell Discovery：“神药”二甲双胍可以抑制三阴性乳腺癌干细胞

2017-09-16

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Nat Commun：促进三阴性乳腺癌扩散转移的“核心原因”已确定

2018-04-30

circumcision (审核中...)

前往app查看评论内容

#阴性乳腺癌#

Oncotarget ：三阴性乳腺癌新突破：科学家首次识别全新治疗靶点

2018-04-04

科室
- - 订阅+
  - 更多科室
工具
服务